HERTHENA-Lung02: Phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI Journal Article
| Authors: | Mok, T.; Jänne, P. A.; Nishio, M.; Novello, S.; Reck, M.; Steuer, C.; Wu, Y. L.; Fougeray, R.; Fan, P. D.; Meng, J.; Sternberg, D. W.; Esker, S.; Yu, H. A. |
| Article Title: | HERTHENA-Lung02: Phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI |
| Journal Title: | Future Oncology |
| Volume: | 20 |
| Issue: | 15 |
| ISSN: | 1479-6694 |
| Publisher: | Future Medicine |
| Date Published: | 2024-05-01 |
| Start Page: | 969 |
| End Page: | 980 |
| Language: | English |
| DOI: | 10.2217/fon-2023-0602 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PUBMED: | 38095056 |
| DOI/URL: | |
| Notes: | Accession Number: 176323011 -- Entry Date: In Process -- Revision Date: 20240401 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Europe; UK & Ireland -- NLM UID: 101256629. -- Source: CINAHL Plus with Full Text |
